Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study

References

• Ostensen M, Clowse M. Pathogenesis of pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 2013;25(5):591–596.
   PubMed Web of Science ®Google Scholar
• Barbhaiya M, Bermas BL. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clin Immunol 2013.
   Google Scholar
• Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008;199(2):127–6.
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42(7):1309–1311.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004;164(1):77–82.
   PubMedGoogle Scholar
• Schramm AM, Clowse ME. Aspirin for prevention of preeclampsia in lupus pregnancy. Autoimmune Dis 2014;2014:920467.
   PubMedGoogle Scholar
• Les I, Ruiz-Irastorza G, Khamashta MA. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome. Semin Thromb Hemost 2012;38(4):339–347.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376(9751):1498–1509.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116 (2 Pt 1): 402–414.
   PubMed Web of Science ®Google Scholar
• Dutch Obstetric Guidelines SLE and pregnancy. 9-11-2007.
   Google Scholar
• Dutch Obstetric Guidelines antiphospholipid syndrome and pregnancy. 9-11-2007.
   Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Dutch Obstetric Guidelines venous thrombo-embolism. 12-6-2009.
   Google Scholar
• Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2Suppl): e691S–e736S.
   Google Scholar
• Danza A, Ruiz-Irastorza G, Khamashta M. Antiphospohlipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol 2012;26(1):65–76.
   PubMed Web of Science ®Google Scholar
• de Jesus GR, Rodrigues G, de Jesus NR, Levy RA. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? Curr Rheumatol Rep 2014;16(2):403.
   PubMed Web of Science ®Google Scholar
• Mecacci F, Bianchi B, Pieralli A, et al. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies. Rheumatology (Oxford) 2009;48(3):246–249.
   PubMed Web of Science ®Google Scholar
• Ambrosio P, Lermann R, Cordeiro A, et al. Lupus and pregnancy–15 years of experience in a tertiary center. Clin Rev Allergy Immunol 2010; 38 (2–3): 77–81.
   PubMed Web of Science ®Google Scholar
• Rodger MA, Hague WM, Kingdom J, et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 2014;384(9955):1673–1683.
   PubMed Web of Science ®Google Scholar
• van Hoorn ME, Hague WM, van Pampus MG, et al. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. Eur J Obstet Gynecol Reprod Biol 2015;197:168–173.
   PubMed Web of Science ®Google Scholar
• D’Ippolito S, Ortiz AS, Veglia M, et al. Low molecular weight heparin in obstetric care: a review of the literature. Reprod Sci 2011;18(7):602–613.
   PubMed Web of Science ®Google Scholar
• Greer IA, Brenner B, Gris JC. Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine? Br J Haematol 2014;165(5):585–599.
   PubMed Web of Science ®Google Scholar
• Sobel ML, Kingdom J, Drewlo S. Angiogenic response of placental villi to heparin. Obstet Gynecol 2011;117(6):1375–1383.
   PubMed Web of Science ®Google Scholar
• Sela S, Natanson-Yaron S, Zcharia E, et al. Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase. Circ Res 2011;108(9):1063–1070.
   PubMed Web of Science ®Google Scholar
• Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004;10(11):1222–1226.
   PubMed Web of Science ®Google Scholar
• Girardi G, Prohaszka Z, Bulla R, et al. Complement activation in animal and human pregnancies as a model for immunological recognition. Mol Immunol 2011;48(14):1621–1630.
   PubMed Web of Science ®Google Scholar
• Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res 2010;125(5):e240–e245.
   PubMed Web of Science ®Google Scholar
• Hagmann H, Bossung V, Belaidi AA, et al. Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination. PLoS One 2014;9(1):e85258.
   Google Scholar
• Bujold E, Roberge S, Nicolaides KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn 2014; (7):642–648.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 2011;38(9):1906–1913.
   PubMed Web of Science ®Google Scholar
• Ateka-Barrutia O, Khamashta M. The challenge of pregnancy for patients with SLE. Lupus 2013;22(12):1295–1308.
   PubMed Web of Science ®Google Scholar
• Jakobsen IM, Helmig RB, Stengaard-Pedersen K. Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990–2010. Scand J Rheumatol 2015;44(5):377–384.
   PubMed Web of Science ®Google Scholar
• Hamed HO, Ahmed SR, Alzolibani A, et al. Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study. Acta Obstet Gynecol Scand 2013;92(8):934–942.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a Cohort Study. Ann Intern Med 2015;163(3):153–163.
   PubMed Web of Science ®Google Scholar